Drug intelligence / Profile preview

Nephgard

Development stage
Unknown
Lead developer
Zaiva Lifesciences
Modality
Small Molecules
Administration
Oral
01

Overview

Nephgard is a branded generic combination pharmaceutical product developed and marketed by Zaiva Lifesciences, primarily indicated for the management of chronic kidney disease (CKD). The formulation typically consists of N-acetylcysteine (NAC) and taurine. N-acetylcysteine serves as a precursor to glutathione, a critical endogenous antioxidant, which helps to neutralize reactive oxygen species and reduce oxidative stress-induced damage in renal tissues. Taurine, a sulfur-containing amino acid, acts as an organic osmolyte and antioxidant, providing cytoprotective effects to renal tubular cells. Together, these components are intended to slow the progression of kidney dysfunction and mitigate the complications associated with chronic renal failure.

Brand names
Nephgard
Other names
N-acetylcysteine + taurine
02

Targets

GSH (Glutathione)

Beyond the preview

Go deeper on Nephgard.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Nephgard.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call